The Importance of Broad Population Immunization to Patients Who Undergo Cancer Treatment
This Viewpoint explores how the association between increased vaccine hesitancy and measles outbreaks affect patients with cancer in the United States.
This Viewpoint explores how the association between increased vaccine hesitancy and measles outbreaks affect patients with cancer in the United States.
This Viewpoint describes the benefits and barriers of conducting cardiovascular disease outcome trials to provide evidence of effectiveness of novel blood pressure (BP)–lowering therapies in…
Patients with cancer may be at high risk of adverse outcomes from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. We analyzed a cohort of…
Patients treated recently for a B-lymphoid malignancy are shown to have particularly high risks of severe COVID-19 compared to multiple control cohorts of patients with…
This cohort study of children and adolescents aged 9 to 12 years evaluates person-level associations between time spent using social media and depressive symptoms over…
This cross-sectional study explores whether the health improvements of people with diabetes have matched the economic progress of this patient population.
This multicenter study uses reinforcement learning to examine the treatment implications of a vasopressin initiation rule developed to improve short-term and hospital outcomes in critically…
This study compares individuals who have discrepant biological and clinical stages with those who have congruent stages in terms of copathologies, comorbidities, and demographics.
This multicenter study uses reinforcement learning to examine the treatment implications of a vasopressin initiation rule developed to improve short-term and hospital outcomes in critically…
This cross-sectional study describes the availability and access cost to the public of research findings and other clinical insights relevant to rare diseases.
This cross-sectional study examines trends in the nutritional composition of children’s ready-to-eat cereals introduced in the US market from 2010 to 2023.